Possibia

5924932

Last Update Posted: 2023-11-03

Recruiting

All Genders

accepted

18 Years +

120 Estimated Participants

No Expanded Access

Observational Study

Does not accept healthy volunteers

Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D

The goal of this study is compare the effect of hybrid closed loop system (HCL) for automatic insulin dosing treatment on the glycemic control of type 1 diabetes (T1D) in patient with different initial glycated hemoglobin.

Rationale for the Study:

According to our hypothesis, even T1D patients with an initially optimal glucose level should benefit from this treatment method in the form of a reduction in glycemic variability.

There are very few clinical studies from real practice in a larger group of patients.

Eligibility

Relevant conditions:

Diabetes Mellitus, Type 1

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Data sourced from ClinicalTrials.gov